With an expiration date still more than a year away, here's what the latest details reveal.
Vyvanse, or its generic counterpart lisdexamfetamine dimesylate, is prescribed to treat ADHD in adults, and children six years of age or older, as well as moderate to sever binge eating disorder (BED) ...
The Food and Drug Administration on Monday announced it had approved generic versions of Vyvanse, an increasingly popular alternative to Adderall. Commonly prescribed ...
Several lots of a generic ADHD medication used by millions are under recall because users may not be getting the full benefit. Sun Pharmaceutical Industries issued the voluntary, nationwide recall for ...
Please provide your email address to receive an email when new articles are posted on . Amneal Pharmaceuticals has received an abbreviated new drug application from the FDA for its lisdexamfetamine ...
Amneal has received the Food and Drug Administration’s green light for lisdexamfetamine dimesylate capsules, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg, and 70 mg. Lisdexamfetamine dimesylate capsules is a ...
ADHD is an acronym that stands for Attention Deficit Hyperactivity Disorder. It’s a condition that can affect a person’s ability to pay attention, stay focused, and control their impulses. Treatment ...
To address the nationwide shortage of medications for attention-deficit/hyperactivity disorder, the Drug Enforcement Administration is allowing an increase in the ...
Lisdexamfetamine dimesylate 30 mg, 50 mg, 70 mg; caps. After oral administration, lisdexamfetamine is rapidly absorbed from the GI tract and is converted to the active drug dextroamphetamine.
Supply from drugmakers for the stimulant medications most commonly prescribed for ADHD are still falling short of demand, the Food and Drug Administration says, and many Americans who rely on these ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results